Ocular Therapeutix Inc
-
Ticker
OCUL
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Bedford, Massachusetts
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for eye diseases and conditions using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a topical liquid hydrogel that creates a sealant to prevent post-surgical leakage from clear corneal incisions during cataract surgery.
REPORT RATINGS
4.7 / 5.0 (151)
Ocular Therapeutix Inc reports have an aggregate usefulness score of 4.7 based on 151 reviews.
Ocular Therapeutix Inc
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports